(Press-News.org) 1. Daily low-dose aspirin may protect against preeclampsia complications
Daily low-dose aspirin beginning as early as the second trimester of pregnancy may prevent complications from preeclampsia, according to an article being published in Annals of Internal Medicine. Preeclampsia is a condition characterized by high blood pressure and proteinuria during the second half of pregnancy. Poor perinatal health outcomes are associated with preeclampsia, primarily due to increased risk for intrauterine growth restriction (IUGR) or medically initiated preterm delivery. Preeclampsia is the leading cause of maternal deaths and is responsible for more than one third of serious maternal morbidities and 15 percent of preterm births. Predicting which patients will develop preeclampsia is not possible but some conditions, such as preeclampsia in a previous pregnancy or chronic illnesses such as diabetes, hypertension, and renal disease put women at high risk. Prevention is imperative because the only effective treatment for preeclampsia is delivery, which may have serious neonatal harms before 34 weeks of gestation. Researchers conducted a systematic evidence review to determine the benefits and harms of low-dose aspirin for preventing morbidity and mortality from preeclampsia. They found that when women at high-risk for preeclampsia started taking a daily low-dose aspirin after their first trimester their risk of developing preeclampsia during the pregnancy dropped by 24-percent. In addition, the risk for preterm birth dropped by 14 percent and the risk for IUGR dropped by 20 percent. No harms of daily low-dose aspirin were identified in the literature. A draft recommendation based on this review will be posted to http://www.uspreventiveservicestaskforce.org on April 7.
Note: The URL will go live at 5:00 p.m. on Monday, April 7 and can be included in news stories. For an embargoed PDF, please contact Megan Hanks or Angela Collom. To speak with the author of the evidence review, please contact Mary Sawyers at Mary.A.Sawyers@kpchr.org or 503-335-6602. For a copy of the draft recommendation, please contact Nicole Raisch at newsroom@uspstf.net or 202-572-2044.
2. Could controversial Canadian mammography study spark new thinking in the U.S.?
A recent report from the Canadian National Breast Screening Study (CNBSS) concluded that mammography screening does not reduce deaths from breast cancer. The findings refueled the heated debate that began in 2009 when the U.S. Preventive Services Task Force recommended biennial mammography screening for women ages 50 to 74 and individualized screening for younger women. Two new commentaries being published in Annals of Internal Medicine discuss the findings of the Canadian study and suggest new approaches to studying and thinking about breast cancer. In the first commentary (http://www.annals.org/article.aspx?doi=10.7326/M14-0569), the authors discuss the conclusiveness of trials that test the benefits and harms of mammography screening and suggest that it may be time for a new kind of study. They argue that the ultimate question for any cancer screening program is whether a reduction in cancer mortality really translates into saved lives. Current trials do not show evidence that mammography screening programs reduce overall mortality. In the second commentary (http://www.annals.org/article.aspx?doi=10.7326/M14-0616), the author suggests that the CNBSS report should help to reframe the issue of breast cancer to include discussion of prevention. The author suggests that we begin to look at screening in a more limited way and focus also on making lifestyle changes that are associated with a reduced risk for breast cancer.
Note: The URL will go live at 5:00 p.m. on Monday, April 7 and can be included in news stories. For an embargoed PDF, please contact Megan Hanks or Angela Collom. To speak with the author of the first commentary, please contact Vanessa Arn at varn@ispm.unibe.ch or +41 31 631 57 93. To speak with the author of the second, please contact William Davis at william_davis@med.unc.edu or 919-966-5906.
INFORMATION:
Annals of Internal Medicine tip sheet for April 8, 2014
2014-04-08
ELSE PRESS RELEASES FROM THIS DATE:
Running geese give insight into low oxygen tolerance
2014-04-08
A new study into how the world's highest flying bird, the bar-headed goose, is able to survive at extreme altitudes may have future implications for low oxygen medical conditions in humans.
An international team of scientists recently tracked the bar-headed goose while it migrated across the Himalayas. Now they have shown how these birds are able to tolerate running at top speed while breathing only 7% oxygen.
Exercising at high altitude is a massive challenge since at the top of the highest mountains the air is only made up of 7% oxygen, compared with 21% at sea level. ...
Faster eye responses in Chinese people not down to culture
2014-04-08
New research from University of Liverpool scientists has cast doubt on the theory that neurological behaviour is a product of culture in people of Chinese origin.
Scientists tested three groups – students from mainland China, British people with Chinese parents and white British people – to see how quickly their eyes reacted to dots appearing in the periphery of their vision.
These rapid eye movements, known as saccades, were timed in all of the participants to see which of them were capable of making high numbers of express saccades – particularly fast responses which ...
For good and ill, immune response to cancer cuts both ways
2014-04-07
The difference between an immune response that kills cancer cells and one that conversely stimulates tumor growth can be as narrow as a "double-edged sword," report researchers at the University of California, San Diego School of Medicine in the April 7, 2014 online issue of the Proceedings of the National Academy of Sciences.
"We have found that the intensity difference between an immune response that stimulates cancer and one that kills it may not be very much," said principal investigator Ajit Varki, MD, Distinguished Professor of Medicine and Cellular and Molecular ...
Genetic predisposition to liking amphetamine reduces risk of schizophrenia and ADHD
2014-04-07
Genetic variants associated with enjoying the effects of d-amphetamine—the active ingredient in Adderall—are also associated with a reduced risk for developing schizophrenia and attention deficit hyperactivity disorder (ADHD), report scientists from the University of Chicago in the Proceedings of the National Academy of Sciences on April 7. The results support a long-standing hypothesis that dopamine, the neurotransmitter connected with the euphoric effects of amphetamine, is related to schizophrenia and ADHD.
"Some of the variants that make you like amphetamine also ...
Scientists find missing piece of air particle equation hiding in the walls
2014-04-07
Laboratory chamber walls have been stealing vapors, causing
researchers to underestimate the formation of secondary organic
aerosol in the atmosphere.
A study published April 7 in PNAS Online Early Edition describes how
a team of scientists, including researchers from the University of
California, Davis, showed that vapor losses to the walls of
laboratory chambers can suppress the formation of secondary organic
aerosol, which in turn has contributed to the underprediction of SOA
in climate and air quality models.
SOA impacts air quality and climate and makes ...
Scientists identify part of brain linked to gambling addiction
2014-04-07
New research reveals that brain damage affecting the insula – an area with a key role in emotions – disrupts errors of thinking linked to gambling addiction. The research, led by Dr Luke Clark from the University of Cambridge, was published today, 07 April, in the journal PNAS.
During gambling games, people often misperceive their chances of winning due to a number of errors of thinking called cognitive distortions. For example, 'near-misses' seem to encourage further play, even though they are no different from any other loss. In a random sequence like tossing a coin, ...
New light shed on key bacterial immune system
2014-04-07
New insights into a surprisingly flexible immune system present in bacteria for combating viruses and other foreign DNA invaders have been revealed by researchers from New Zealand's University of Otago and the Netherlands.
A team led by Dr Peter Fineran of the Department of Microbiology and Immunology are studying the genetic basis of adaptive immunity in bacteria that cause potato 'soft rot' and in E. coli bacteria. Through their recent collaboration they have found that these bacterial immune systems are much more robust and responsive than previously thought.
Their ...
Genes increase the stress of social disadvantage for some children
2014-04-07
Genes amplify the stress of harsh environments for some children, and magnify the advantage of supportive environments for other children, according to a study that's one of the first to document how genes interacting with social environments affect biomarkers of stress.
"Our findings suggest that an individual's genetic architecture moderates the magnitude of the response to external stimuli—but it is the environment that determines the direction" says Colter Mitchell, lead author of the paper and a researcher at the University of Michigan Institute for Social Research ...
Targeting sperm protection in mosquitoes could help combat malaria
2014-04-07
Researchers have discovered a way of reducing the fertility of malaria-carrying mosquitoes, potentially providing a new tactic to combat the disease.
Anopheles gambiae mosquitoes are the main transmitters of malaria, which affects around 200 million people every year. The females mate only once during their lives. They store the sperm from this single mating in an organ called the spermatheca, from which they repeatedly take sperm over the course of their lifetime to fertilise the eggs that they lay..
The female needs the sperm to stay healthy whilst they are in storage ...
Solution to platelet 'puzzle' uncovers blood disorder link
2014-04-07
Melbourne researchers have solved a puzzle as to how an essential blood-making hormone stimulates production of the blood clotting cells known as platelets.
Platelets are essential for stopping bleeding and are produced by small fragments breaking off their 'parent' cells, called megakaryocytes.
The discovery, made by scientists at the Walter and Eliza Hall Institute, identified how bone marrow cells could become overstimulated and produce too many platelets. In blood diseases such as essential thrombocythemia, too many platelets can lead to clogging of the blood vessels, ...